South Dakota Investment Council’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,536
| Closed | -$87K | – | 592 |
|
|
2021
Q3 | $87K | Sell |
1,536
-26,000
| -94% | -$1.47M | ﹤0.01% | 567 |
|
|
2021
Q2 | $1.21M | Buy |
27,536
+10,790
| +64% | +$475K | 0.02% | 441 |
|
|
2021
Q1 | $826K | Buy |
16,746
+9,846
| +143% | +$486K | 0.01% | 498 |
|
|
2020
Q4 | $290K | Hold |
6,900
| – | – | 0.01% | 563 |
|
|
2020
Q3 | $316K | Hold |
6,900
| – | – | 0.01% | 533 |
|
|
2020
Q2 | $346K | Hold |
6,900
| – | – | 0.01% | 513 |
|
|
2020
Q1 | $355K | Hold |
6,900
| – | – | 0.01% | 482 |
|
|
2019
Q4 | $426K | Sell |
6,900
-1,900
| -22% | -$117K | 0.01% | 509 |
|
|
2019
Q3 | $529K | Buy |
8,800
+8,000
| +1,000% | +$481K | 0.01% | 520 |
|
|
2019
Q2 | $68K | Hold |
800
| – | – | ﹤0.01% | 590 |
|
|
2019
Q1 | $76K | Buy |
+800
| New | +$76K | ﹤0.01% | 587 |
|